This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Aug;80(2):312-3.

doi: 10.1002/ana.24701. Epub 2016 Jun 24.

Reply

Vaishali S Janve¹, Ciria C Hernandez², Kelienne M Verdier², Ningning Hu², Robert L Macdonald²

Affiliations

PMID: 27270493
DOI: 10.1002/ana.24701

Comment

Reply

Vaishali S Janve et al. Ann Neurol. 2016 Aug.

. 2016 Aug;80(2):312-3.

doi: 10.1002/ana.24701. Epub 2016 Jun 24.

Authors

Vaishali S Janve¹, Ciria C Hernandez², Kelienne M Verdier², Ningning Hu², Robert L Macdonald²

Affiliations

¹ Graduate Program of Neuroscience, Nashville, TN.
² Department of Neurology, Vanderbilt University, Nashville, TN.

PMID: 27270493
DOI: 10.1002/ana.24701

No abstract available

PubMed Disclaimer

Comment on

Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.
Janve VS, Hernandez CC, Verdier KM, Hu N, Macdonald RL. Janve VS, et al. Ann Neurol. 2016 May;79(5):806-825. doi: 10.1002/ana.24631. Ann Neurol. 2016. PMID: 26950270 Free PMC article.
A second patient with a De Novo GABRB1 mutation and epileptic encephalopathy.
Lien E, Våtevik AK, Østern R, Haukanes BI, Houge G. Lien E, et al. Ann Neurol. 2016 Aug;80(2):311-2. doi: 10.1002/ana.24699. Epub 2016 Jun 28. Ann Neurol. 2016. PMID: 27273810 No abstract available.

Publication types

Actions
Actions

Grants and funding

R01 NS033300/NS/NINDS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations